ALKS – alkermes plc - ordinary shares (US:NASDAQ)

News

Alkermes to Participate in Two Upcoming Investor Conferences
Alkermes (NASDAQ:ALKS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc [Yahoo! Finance]
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com